James T. Handa, M.D., is Chief of the Retina Division and the Robert Bond Welch, M.D., Professor of Ophthalmology at the Wilmer Eye Institute. He specializes in medical and surgical management of complex vitreoretinal diseases such as age-related macular degeneration, diabetic retinopathy, retinal detachment, retinopathy of prematurity and other pediatric retinal diseases. He also has expertise in intraocular oncology and manages patients with choroidal melanomas and metastatic tumors of the eye. Not only is he a highly skilled surgeon and clinician, but he also devotes significant effort to research related to the early causes of age-related macular degeneration using molecular pathological approaches to understand how the eye transforms from normal aging to early disease. He has been funded by the National Eye Institute for the last 19 years, and he currently holds two R01 awards for his work in AMD. He has also been funded by the Thome Foundation, Research to Prevent Blindness, Fight for Sight and the American Health Assistance Foundation. His other research focuses on surgical innovation using an integrated robotic surgical system. Dr. Handa is currently the Wilmer Eye Institute’s implanting surgeon for the Argus II retinal chip implant, which was recently approved by the FDA after Dr. Handa participated in the clinical trial leading to its approval. Dr. Handa is rated as a Distinguished provider by MediFind in the treatment of Metastatic Uveal Melanoma. His top areas of expertise are Melanoma of the Eye, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Metastatic Uveal Melanoma, and Vitrectomy.

Dr. Lipson is an internationally-recognized skin cancer and immunotherapy specialist at Johns Hopkins. He received his medical degree in 2005 from the Mount Sinai School of Medicine in New York City, where he graduated with distinction in research. He completed his internship and residency in Internal Medicine at The Johns Hopkins Hospital, and completed a Medical Oncology fellowship at the Johns Hopkins Kimmel Cancer Center. Dr. Lipson leads cutting edge clinical trials for patients with melanoma and other skin cancers. As a member of the Johns Hopkins Melanoma and Cancer Immunology Programs, he focuses on evaluating novel therapies for patients with high-risk or advanced disease. Dr. Lipson’s publications include the first reports of organ transplant recipients treated with immune checkpoint inhibitors for advanced cancer, and the first description of kidney retransplantation performed after immunotherapy–related organ rejection. Based on his published work, Dr. Lipson initiated a clinical trial testing a novel combination of immune-based therapies for kidney transplant recipients with advanced selected cancers. Results from this trial - the first of its kind - were reported in 2022 at an international oncology meeting. Dr. Lipson is a leader in the clinical development of relatlimab, an antibody blocking the LAG-3 immune checkpoint. He leads a phase 2 trial testing combination immune checkpoint inhibitor therapy—including anti-LAG-3—for patients with advanced basal cell carcinoma. In June 2021, Dr. Lipson presented findings from the first phase 3 study establishing the LAG-3 pathway as the third immune checkpoint pathway in history, after CTLA-4 and PD-1, for which blockade has clinical benefit. This trial supported the FDA's approval of a new therapy for patients with advanced melanoma. In addition to his research activities, Dr. Lipson is an educator in the field of cancer immunotherapy. Many of his lectures focus on the management of immune-mediated drug toxicities associated with novel cancer drugs. Dr. Lipson conducts regular clinical practices in Baltimore, Maryland and at Sibley Memorial Hospital in Washington, D.C. as part of the multidisciplinary Melanoma Program at Johns Hopkins. Dr. Lipson is rated as a Distinguished provider by MediFind in the treatment of Metastatic Uveal Melanoma. His top areas of expertise are Melanoma, Merkel Cell Carcinoma, Melanoma of the Eye, Metastatic Uveal Melanoma, and Pancreaticoduodenectomy.

Dr. Harry Quon is an associate professor of radiation oncology and molecular radiation sciences at the Johns Hopkins University School of Medicine. He also holds appointments in oncology and in otolaryngology - head and neck surgery. His area of clinical expertise is radiation treatment for head and neck cancers. He serves as the co-director of the Johns Hopkins Head and Neck Cancer Multidisciplinary Clinic. Dr. Quon received his M.D. from the University of Toronto Institute of Medical Science. He completed his residency at the Princess Margaret Hospital in Ontario and performed a fellowship in radiation oncology at the Princess Margaret Hospital and the Beth Israel Medical Center. Make A Gift. Dr. Quon is rated as a Distinguished provider by MediFind in the treatment of Metastatic Uveal Melanoma. His top areas of expertise are Laryngeal Cancer, Throat Cancer, Dry Mouth, Gastrostomy, and Prostatectomy.

Akrit Sodhi, M.D, Ph.D., is an Associate Professor of Ophthalmology at the Wilmer Eye Institute and holds the Branna and Irving Sisenwein Professorship in Ophthalmology. Dr. Sodhi specializes in the medical and surgical management of complex vitreoretinal diseases. Dr. Sodhi was trained at the University of California at Los Angeles (UCLA), the University of California at Davis, and the National Institutes of Health. After obtaining his M.D. and Ph.D., he interned at Sinai Hospital in Baltimore and completed his Ophthalmology Residency training at the Wilmer Eye Institute at Johns Hopkins in 2008. He then pursued a fellowship in vitreoretinal surgery at Wilmer where he also served as the Assistant Chief of Service (Chief Resident). Dr. Sodhi joined the faculty of the Retina Division at Wilmer in 2010. His research interests, currently sponsored by grants from the National Eye Institute, include the examination of the role of hypoxia inducible factor (HIF) and HIF-regulated genes in ocular diseases, including diabetic eye disease, age-related macular degeneration, sickle cell retinopathy, retinal vein occlusions, and uveal melanoma. Dr. Sodhi's lab has identified novel therapeutic targets for the treatment of these vision-threatening diseases. Dr. Sodhi is rated as an Advanced provider by MediFind in the treatment of Metastatic Uveal Melanoma. His top areas of expertise are Retinal Vein Occlusion, Age-Related Macular Degeneration (ARMD), Diabetic Retinopathy, and Late-Onset Retinal Degeneration.

Dr. Ana Kiess's clinical focus is on the treatment of prostate cancer and head and neck cancers with external beam radiotherapy and radiopharmaceutical therapies. Her research concentrates on the integration of new radiopharmaceutical therapies and dosimetry techniques into the clinic. Dr. Kiess received her bachelors of science degree in chemical engineering from the University of Virginia, after which she obtained a doctorate of medicine and a doctorate of philosophy degree in biomedical engineering from Duke University. Following medical school, she matriculated to the resident staff at Memorial Sloan Kettering Cancer Center, receiving extensive oncologic training and research experience. She also completed a postdoctoral research fellowship at Johns Hopkins University in the Department of Radiology. Make A Gift. Dr. Kiess is rated as an Experienced provider by MediFind in the treatment of Metastatic Uveal Melanoma. Her top areas of expertise are Prostate Cancer, Laryngeal Cancer, Throat Cancer, Gastrostomy, and Adenoidectomy.

Fernando Arevalo is an Ophthalmologist in Baltimore, Maryland. Dr. Arevalo is rated as an Experienced provider by MediFind in the treatment of Metastatic Uveal Melanoma. His top areas of expertise are Gyrate Atrophy of the Choroid and Retina, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, and Diabetic Retinopathy.

William Houck is an Oncologist in Baltimore, Maryland. Dr. Houck is rated as an Experienced provider by MediFind in the treatment of Metastatic Uveal Melanoma. His top areas of expertise are Paget Disease of the Breast, Lung Cancer, Chronic B-Cell Leukemia (CBCL), and Chronic Lymphocytic Leukemia (CLL).

Aliyah Pabani, M.D., M.P.H. is an Assistant Professor of Oncology at the Sidney Kimmel Comprehensive Cancer at Johns Hopkins in the Upper Aerodigestive Cancer Division (UAD). She is Co-Director of the Immune-Related (IR) Toxicity Team. Dr. Pabani completed Internal Medicine residency and Medical Oncology fellowship at the University of Alberta after which she pursued an Advanced Thoracic Oncology fellowship at Columbia University. She also received a Masters of Public Health from Harvard University. Dr. Pabani conducts clinical and translational research in immunotherapy-related adverse events and immunotherapy in squamous cell cancers. She cares for patients primarily at the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center at Skip Viragh Outpatient Cancer Center and Johns Hopkins Bayview Medical Center. Dr. Pabani is rated as an Experienced provider by MediFind in the treatment of Metastatic Uveal Melanoma. Her top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Melanoma, and Small Cell Lung Cancer (SCLC).

Dr. Warrier is a medical oncologist at Johns Hopkins who specializes in caring for patients with high-risk and advanced skin cancers (e.g., melanoma, cutaneous squamous cell carcinoma, basal cell carcinoma, and Merkel cell carcinoma). This includes expertise with state-of-the-art immunotherapy, targeted therapy, and chemotherapy treatments, as well as optimal surveillance approaches for cancer. Dr. Warrier’s clinical practice is in Baltimore, Maryland. Dr. Warrier received his medical degree in 2017 from the University of Louisville School of Medicine, where he graduated with distinction in research. He completed his internship and residency in Internal Medicine at The University of Michigan and spent an additional year serving as chief resident. He subsequently completed a Medical Oncology fellowship at Johns Hopkins University, where he also served as chief medical oncology fellow. As a member of the Johns Hopkins Melanoma/Skin Cancer and Cancer Immunology Programs, Dr. Warrier is actively engaged in research focused on improving outcomes for patients with skin cancers. As part of his research, he helps develop and lead innovative clinical trials focused on developing better, and safer, cancer treatments and monitoring approaches. Dr. Warrier is additionally interested in improving cancer care delivery through digital health initiatives. He is currently helping lead study and development of a novel digital patient navigation platform aiming to help patients with melanoma around the country better understand their diagnosis, get connected with melanoma experts, and learn about clinical trials. In addition to his clinical and research activities, Dr. Warrier is a dedicated educator. Dr. Warrier is regularly engaged in teaching medical trainees and other health professionals. He has also published several manuscripts focused on patient education in JAMA Internal Medicine. Dr. Warrier is rated as an Experienced provider by MediFind in the treatment of Metastatic Uveal Melanoma. His top areas of expertise are Melanoma and Metastatic Uveal Melanoma.

Jonaphine Mata is a primary care provider, practicing in Oncologist in Baltimore, Maryland. Dr. Mata is rated as an Experienced provider by MediFind in the treatment of Metastatic Uveal Melanoma. Her top area of expertise is Metastatic Uveal Melanoma.

Franco Verde is a Radiologist in Baltimore, Maryland. Dr. Verde is rated as an Experienced provider by MediFind in the treatment of Metastatic Uveal Melanoma. His top areas of expertise are ALK-Positive Non-Small Cell Lung Cancer, Lung Nodules, Gas Bloat Syndrome, and Visceromegaly.

David Reisner is a Radiologist in Baltimore, Maryland. Dr. Reisner is rated as an Experienced provider by MediFind in the treatment of Metastatic Uveal Melanoma. His top areas of expertise are Fibrolamellar Carcinoma, Wandering Spleen, Cholangiocarcinoma (Bile Duct Cancer), and Ampullary Cancer.

Syed Nasir is a Hematologist and an Oncologist in Towson, Maryland. His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Lynch Syndrome, and Paget Disease of the Breast.

Dr. William H. Sharfman is an associate professor of oncology and dermatology at the Johns Hopkins University School of Medicine. His areas of clinical expertise include cutaneous oncology, dermatology and immunotherapy. He helped create the well-established Melanoma Program at the Johns Hopkins Kimmel Cancer Center in 1994. Dr. Sharfman serves as the director of cutaneous oncology and clinical co-director for oncology at the Johns Hopkins Melanoma Program. He earned his M.D. from the University of Toledo College of Medicine. He completed his residency at Cleveland Clinic and performed a fellowship in hematology and oncology at Cleveland Clinic. Dr. Sharfman's research interests include novel therapies for high risk and advanced melanoma patients. Dr. Sharfman is rated as an Experienced provider by MediFind in the treatment of Metastatic Uveal Melanoma. His top areas of expertise are Melanoma, Merkel Cell Carcinoma, Eccrine Porocarcinoma, and Familial Pancreatic Cancer.

Elizabeth Bower is a primary care provider, practicing in Internal Medicine in Ellicott City, Maryland. Dr. Bower is rated as an Experienced provider by MediFind in the treatment of Metastatic Uveal Melanoma. Her top areas of expertise are Familial Combined Hyperlipidemia, Xanthoma, Cirrhosis, and High Cholesterol.

Vishal Jindal is a Hematologist Oncology specialist and a Hematologist in Baltimore, Maryland. Dr. Jindal is rated as an Experienced provider by MediFind in the treatment of Metastatic Uveal Melanoma. His top areas of expertise are Atheroembolic Renal Disease, Thrombocytopenia, Splenic Infarction, and Anemia. Dr. Jindal is currently accepting new patients.

Raymond Sjaarda is an Ophthalmologist in Baltimore, Maryland. Dr. Sjaarda is rated as an Experienced provider by MediFind in the treatment of Metastatic Uveal Melanoma. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Geographic Atrophy, Retinal Detachment, and Vitrectomy. Dr. Sjaarda is currently accepting new patients.

Kevin Chen is a Hematologist and an Oncologist in Baltimore, Maryland. His top areas of expertise are Small Cell Lung Cancer (SCLC), ALK-Positive Non-Small Cell Lung Cancer, Lung Adenocarcinoma, and Squamous Cell Lung Carcinoma.

Richard Scholz is an Ophthalmologist in Towson, Maryland. Dr. Scholz is rated as an Experienced provider by MediFind in the treatment of Metastatic Uveal Melanoma. His top areas of expertise are Glaucoma, Meibomianitis, Cataract, and Subconjunctival Hemorrhage. Dr. Scholz is currently accepting new patients.

Shivang Danak is a Hematologist and an Oncologist in Glen Burnie, Maryland. Dr. Danak is rated as an Experienced provider by MediFind in the treatment of Metastatic Uveal Melanoma. His top areas of expertise are Splenomegaly, Lymphofollicular Hyperplasia, Teratoma of the Mediastinum, and Metastatic Uveal Melanoma.